Arthritis and Rheumatology
ISSN: 2326-5191
eISSN: 2326-5205
Publisher: Wiley
Publications (222)
Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis (2025)
Chenguiti Fakhouri S, Zhu H, Li YN, Ronicke M, Rigau AR, Dees C, Konstantinidis L, et al.
Journal article
Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease (2025)
Topping J, Chang L, Nadat F, Poulter JA, Ibbotson A, Lara-Reyna S, Watson CM, et al.
Journal article
Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al (2025)
Sulu B, Tascilar K
Journal article, Letter
EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of Arthralgia (2025)
van Steenbergen HW, Doornkamp F, Alivernini S, Backlund J, Codreanu C, Cohen SB, Combe B, et al.
Journal article
Antifibrotic effects of specific targeting of the 5-hydroxytryptamine 2B receptor (5-HT2BR) in murine models and ex vivo models of scleroderma skin (2025)
Trinh-Minh T, Tran-Manh C, Györfi AH, Dickel N, Liebel C, Zhou X, Wang J, et al.
Journal article
Unveiling Metabolic Similarities of Entheses in Patients with Psoriasis and Psoriatic Arthritis Using Noninvasive In Vivo Molecular Imaging: Results From a Cross-sectional Exploratory Study (2024)
Fagni F, Tascilar K, Noversa de Sousa R, Bayat S, Sollfrank L, Kleyer A, Sticherling M, et al.
Journal article
Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis–Specific Transcriptional Signatures in Human Skin (2024)
Trinh-Minh T, Györfi AH, Tomcik M, Tran-Manh C, Zhou X, Dickel N, Tümerdem BS, et al.
Journal article
CCL19‐positive lymph node stromal cells govern the onset of inflammatory arthritis via tropomyosin receptor kinase (2024)
Schälter F, Azizov V, Frech M, Dürholz K, Schmid E, Hendel A, Sarfati I, et al.
Journal article
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis (2024)
Siebert S, Coates LC, Schett G, Raychaudhuri SP, Chen W, Gao S, Seridi L, et al.
Journal article
Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach. (2024)
Fagni F, Motta F, Schett G, Selmi C
Journal article